Skip to main content

Together we are beating cancer

Donate now

Science & Technology

Read the latest in pre-clinical research, drug discovery and new technologies in cancer
Showing 12 out of 1547 results
This entry is part 24 of 30 in the series That Cancer Conversation
Microscope image of human colon cancer cells
  • Science & Technology
  • Health & Medicine

Bowel cancer awareness month: Common questions answered

To help raise awareness around bowel cancer, and the research we are doing, we’re answering some the most common questions on bowel cancer. To help raise awareness around bowel cancer, and the research we are doing, we’re answering some the most common questions on bowel cancer.

by Amy Warnock | In depth | 1 April 2025

1 April 2025

Researchers discussing work in lab

Along with our partners, we've committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. Along with our partners, we've committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer.

by Fiona Scott | News | 31 March 2025

31 March 2025

A group of postgraduate researchers working in a laboratory at the University of Nottingham.
  • Science & Technology
  • Health & Medicine
  • Charity News

Our Teenage and Young Adult Cancer Awareness Month research roundup

Around 2,200 teenagers and young adults are diagnosed with cancer in the UK every year. For Teenage and Young Adult Cancer Awareness Month, we're highlighting some of the ways we're working to help them. Around 2,200 teenagers and young adults are diagnosed with cancer in the UK every year. For Teenage and Young Adult Cancer Awareness Month, we're highlighting some of the ways we're working to help them.

by Ben Sammon, Tim Gunn | In depth | 26 March 2025

26 March 2025

This entry is part 23 of 30 in the series That Cancer Conversation
Head shots of Dr Lian Ni Lee, Sânziana Foia and Professor Christine Harrison

For International Women's Day 2025, we're celebrating three inspirational women and the contributions they have made to cancer research For International Women's Day 2025, we're celebrating three inspirational women and the contributions they have made to cancer research

by Amy Warnock | In depth | 8 March 2025

8 March 2025

Lung cancer cells seen through a microscope, in shades of purple and green,

Cancer Grand Challenges is offering up to £20m funding to teams that can answer seven of the biggest and most important questions in cancer. Cancer Grand Challenges is offering up to £20m funding to teams that can answer seven of the biggest and most important questions in cancer.

by Tim Gunn | News | 5 March 2025

5 March 2025

The DETERMINE trial team celebrating at the Bionow awards

Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements. Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements.

by Tim Bodicoat | In depth | 28 February 2025

28 February 2025

A green beam of light from a radiotherapy machine.

Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story. Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story.

by Tim Gunn | In depth | 17 February 2025

17 February 2025

Lab-grown bowel cancer cells seen through a microscope. They are colour-enhanced and appear blue.

A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists.  A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists. 

by Tim Gunn | News | 30 January 2025

30 January 2025

A microscope image showing immune cells in bowel cancer.

A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects. A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects.

by Sadaf Shafaghmotlagh, Tim Gunn | Analysis | 27 January 2025

27 January 2025